Ji Luo
Impact in
- Cancer Research top 0.5%
- Molecular Biology top 0.2%
- PI3K/AKT/mTOR signaling in cancer
- DNA Repair Mechanisms
- Ubiquitin and proteasome pathways
- Protein Kinase Regulation and GTPase Signaling
- CRISPR and Genetic Engineering
- Cell death mechanisms and regulation
- RNA modifications and cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 16
- Protein Kinase Regulation and GTPase Signaling 14
- CRISPR and Genetic Engineering 9
- RNA modifications and cancer 8
- Ubiquitin and proteasome pathways 8
- Metabolism, Diabetes, and Cancer 7
- Advanced biosensing and bioanalysis techniques 6
- Oncology 26
- Cancer-related Molecular Pathways 16
- Co-authors
- Lewis C. Cantley (22 shared papers)Jeffrey A. Engelman (3 shared papers)Stephen J. Elledge (8 shared papers)Nicole L. Solimini (5 shared papers)Brendan D. Manning (1 shared paper)Adrienne D. Cox (1 shared paper)Stephen W. Fesik (1 shared paper)Alec C. Kimmelman (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (10 papers)Cell (4 papers)Science (4 papers)Nature Communications (4 papers)Cancer Research (4 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Ji Luo
105 papers receiving 17.8k citations
Ji Luo's Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 2.8k
- Molecular Biology 12.8k
- Oncology 4.3k
- Cell Biology 1.8k
- Genetics 786
Countries citing papers authored by Ji Luo
This map shows the geographic impact of Ji Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Luo more than expected).
Fields of papers citing papers by Ji Luo
This network shows the impact of papers produced by Ji Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Luo. The network helps show where Ji Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism Hit paper breakdown → | 2006 | 2790 |
| 2 | ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage Hit paper breakdown → | 2007 | 2526 |
| 3 | Drugging the undruggable RAS: Mission Possible? Hit paper breakdown → | 2014 | 1592 |
| 4 | Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction Hit paper breakdown → | 2009 | 1498 |
| 5 | Targeting the PI3K-Akt pathway in human cancer Hit paper breakdown → | 2003 | 1128 |
| 6 | A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene Hit paper breakdown → | 2009 | 852 |
| 7 | Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis Hit paper breakdown → | 2012 | 789 |
| 8 | NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis Hit paper breakdown → | 2016 | 646 |
| 9 | 2007 | 574 | |
| 10 | 2005 | 435 | |
| 11 | 2011 | 353 | |
| 12 | 2008 | 302 | |
| 13 | 2008 | 301 | |
| 14 | 2007 | 298 | |
| 15 | KRAS mutation in pancreatic cancer Hit paper breakdown → | 2021 | 256 |
| 16 | 2006 | 253 | |
| 17 | 2005 | 173 | |
| 18 | 2012 | 163 | |
| 19 | 2005 | 138 | |
| 20 | 2006 | 137 |
About Ji Luo
Ji Luo is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Immunology, having authored 109 papers that have together received 18.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (16 papers), PI3K/AKT/mTOR signaling in cancer (16 papers), Protein Kinase Regulation and GTPase Signaling (14 papers), CRISPR and Genetic Engineering (9 papers), RNA modifications and cancer (8 papers), Ubiquitin and proteasome pathways (8 papers), Metabolism, Diabetes, and Cancer (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Cancer Research (2.8k citations), Molecular Biology (12.8k citations), Oncology (4.3k citations), Cell Biology (1.8k citations) and Genetics (786 citations). Ji Luo has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Lewis C. Cantley, Jeffrey A. Engelman, Stephen J. Elledge, Nicole L. Solimini, Brendan D. Manning, Adrienne D. Cox, Stephen W. Fesik, Alec C. Kimmelman, Channing J. Der and Agata Smogorzewska. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cell, Science, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.